About this FactMed analysis covering adverse side effect reports of CRESTOR patients who developed OCCIPITAL NEURALGIA.

FactMed provides MD-approved analysis to help both patients, researchers, and physicians accurately assess the risk profile for more than 20,000 different pharmaceutical products. The below report offers compiled information from Food & Drug Administration and FactMed user submissions. Between January 2004 and October 2012, 19 individuals taking CRESTOR reported OCCIPITAL NEURALGIA to the FDA. A total of 57104 CRESTOR drug adverse event reaction reports were made with the FDA during this time period. Often the FDA only receives reports of the most critical and severe cases; these numbers may therefore underrepresent the complication rate of the medication.

FDA Research Report

Introduction This page is designed to help you determine the relationship, if any, between CRESTOR and OCCIPITAL NEURALGIA. In doing so, we compare CRESTOR with other drugs that cause OCCIPITAL NEURALGIA, to help you evaluate whether or not CRESTOR causes OCCIPITAL NEURALGIA. Likewise, this page shows the most highly-reported side effects of CRESTOR, so you can see if OCCIPITAL NEURALGIA ranks among CRESTOR's most well-known side effects.
Summary Statistics
Reports of CRESTOR causing OCCIPITAL NEURALGIA: 19
Reports of any side effect of CRESTOR : 57104
Percentage of CRESTOR patients where OCCIPITAL NEURALGIA is a reported side effect: 0.0333%

FDA reports of any drug causing OCCIPITAL NEURALGIA : 117
Average percentage for all medicated patients where OCCIPITAL NEURALGIA is reported as a complication: 0.0007%

Physician opinion on CRESTOR as adverse event culprit:

Overall opinion for all reports of this drug:
Most frequent diagnoses/indications for prescribing CRESTOR:
BLOOD CHOLESTEROL INCREASED ( 8450 patients )
HYPERCHOLESTEROLAEMIA ( 4097 patients )
PRODUCT USED FOR UNKNOWN INDICATION ( 2846 patients )
HYPERLIPIDAEMIA ( 1945 patients )
BLOOD CHOLESTEROL ( 1358 patients )
DRUG USE FOR UNKNOWN INDICATION ( 1035 patients )
DYSLIPIDAEMIA ( 935 patients )
BLOOD CHOLESTEROL ABNORMAL ( 398 patients )
BLOOD TRIGLYCERIDES INCREASED ( 240 patients )
LOW DENSITY LIPOPROTEIN INCREASED ( 183 patients )
CORONARY ARTERY DISEASE ( 127 patients )
HYPERTENSION ( 99 patients )
LIPIDS INCREASED ( 96 patients )
PROPHYLAXIS ( 94 patients )
HYPERTRIGLYCERIDAEMIA ( 86 patients )
TYPE IIA HYPERLIPIDAEMIA ( 76 patients )
CARDIAC DISORDER ( 73 patients )
ARTERIOSCLEROSIS ( 58 patients )
HIGH DENSITY LIPOPROTEIN DECREASED ( 55 patients )
LIPIDS ABNORMAL ( 55 patients )
MYOCARDIAL INFARCTION ( 53 patients )
DIABETES MELLITUS ( 40 patients )
CARDIOVASCULAR EVENT PROPHYLAXIS ( 35 patients )
MYOCARDIAL ISCHAEMIA ( 35 patients )
METABOLIC DISORDER ( 34 patients )
BLOOD CHOLESTEROL DECREASED ( 31 patients )
LIPIDS ( 27 patients )
ILL-DEFINED DISORDER ( 24 patients )
BLOOD TRIGLYCERIDES ( 22 patients )
HIGH DENSITY LIPOPROTEIN INCREASED ( 22 patients )
LOW DENSITY LIPOPROTEIN ( 20 patients )
HYPOCHOLESTEROLAEMIA ( 16 patients )
ANGINA PECTORIS ( 15 patients )
CEREBROVASCULAR ACCIDENT ( 15 patients )
LIPID METABOLISM DISORDER ( 14 patients )
HYPERCHLORAEMIA ( 14 patients )
LOW DENSITY LIPOPROTEIN DECREASED ( 13 patients )
MIXED HYPERLIPIDAEMIA ( 13 patients )
DIABETES MELLITUS NON-INSULIN-DEPENDENT ( 13 patients )
ARTERIAL OCCLUSIVE DISEASE ( 13 patients )
BLOOD PRESSURE ( 12 patients )
THROMBOSIS PROPHYLAXIS ( 11 patients )
C-REACTIVE PROTEIN INCREASED ( 10 patients )
ISCHAEMIC HEART DISEASE PROPHYLAXIS ( 9 patients )
CARDIOVASCULAR DISORDER ( 9 patients )
PERIPHERAL VASCULAR DISORDER ( 9 patients )
CAROTID ARTERY DISEASE ( 8 patients )
MYALGIA ( 8 patients )
CORONARY ARTERY OCCLUSION ( 8 patients )
TYPE 2 DIABETES MELLITUS ( 7 patients )
ATRIAL FIBRILLATION ( 7 patients )
BLOOD TRIGLYCERIDES ABNORMAL ( 7 patients )
STENT PLACEMENT ( 7 patients )
CAROTID ARTERY OCCLUSION ( 7 patients )
INFARCTION ( 6 patients )
CORONARY ARTERY BYPASS ( 6 patients )
SEPSIS ( 6 patients )
ATHEROSCLEROSIS PROPHYLAXIS ( 6 patients )
ACUTE MYOCARDIAL INFARCTION ( 6 patients )
RENAL DISORDER ( 6 patients )
ACUTE CORONARY SYNDROME ( 5 patients )
ACUTE RESPIRATORY DISTRESS SYNDROME ( 5 patients )
ARTERIOSCLEROSIS CORONARY ARTERY ( 5 patients )
PERIPHERAL ARTERIAL OCCLUSIVE DISEASE ( 5 patients )
FOETAL EXPOSURE DURING PREGNANCY ( 5 patients )
ARTHRITIS ( 5 patients )
RENAL FAILURE CHRONIC ( 4 patients )
HIGH DENSITY LIPOPROTEIN ( 4 patients )
ARTERIAL DISORDER ( 4 patients )
C-REACTIVE PROTEIN ABNORMAL ( 4 patients )
GASTROOESOPHAGEAL REFLUX DISEASE ( 4 patients )
BLOOD PRESSURE INCREASED ( 4 patients )
CORONARY ARTERIAL STENT INSERTION ( 4 patients )
TYPE V HYPERLIPIDAEMIA ( 4 patients )
HYPERLIPASAEMIA ( 4 patients )
VEIN DISORDER ( 4 patients )
DRUG EXPOSURE DURING PREGNANCY ( 3 patients )
BLOOD PRESSURE ABNORMAL ( 3 patients )
OBSTRUCTION ( 3 patients )
RHABDOMYOLYSIS ( 3 patients )
ARTERIAL STENOSIS ( 3 patients )
CAROTID ARTERY STENOSIS ( 3 patients )
OSTEOARTHRITIS ( 3 patients )
BLOOD CORTICOTROPHIN DECREASED ( 3 patients )
HYPO HDL CHOLESTEROLAEMIA ( 3 patients )
MUSCLE SPASMS ( 3 patients )
ASTHMA ( 3 patients )
CARDIAC FAILURE ( 3 patients )
DRUG INTOLERANCE ( 3 patients )
LOW DENSITY LIPOPROTEIN ABNORMAL ( 3 patients )
LDL/HDL RATIO INCREASED ( 3 patients )
ANGINA UNSTABLE ( 3 patients )
BLOOD DISORDER ( 3 patients )
VENTRICULAR HYPERTROPHY ( 3 patients )
LIVER DISORDER ( 3 patients )
ATHEROSCLEROSIS ( 2 patients )
IDIOPATHIC THROMBOCYTOPENIC PURPURA ( 2 patients )
MYOPATHY ( 2 patients )
ARTERIAL INSUFFICIENCY ( 2 patients )
MALAISE ( 2 patients )
VASCULAR BYPASS GRAFT ( 2 patients )
FAMILIAL RISK FACTOR ( 2 patients )
SKIN DISORDER ( 2 patients )
METABOLIC SYNDROME ( 2 patients )
CEREBRAL INFARCTION ( 2 patients )
PULMONARY ARTERIAL HYPERTENSION ( 2 patients )
VASOSPASM ( 2 patients )
THROMBOCYTOPENIA ( 2 patients )
CARDIAC ABLATION ( 2 patients )
BLOOD HOMOCYSTEINE INCREASED ( 2 patients )
CHOLESTEROSIS ( 2 patients )
HEPATIC STEATOSIS ( 2 patients )
PLAGUE ( 2 patients )
ARRHYTHMIA ( 2 patients )
TYPE II HYPERLIPIDAEMIA ( 2 patients )
ATRIOVENTRICULAR BLOCK ( 2 patients )
RETINAL VEIN OCCLUSION ( 2 patients )
ARTERIAL INJURY ( 2 patients )
POST PROCEDURAL COMPLICATION ( 2 patients )
CAROTID ARTERIOSCLEROSIS ( 2 patients )
CORONARY ARTERY SURGERY ( 2 patients )
HYPERTROPHIC CARDIOMYOPATHY ( 2 patients )
BLOOD LACTATE DEHYDROGENASE INCREASED ( 2 patients )
HEART VALVE INCOMPETENCE ( 2 patients )
VERY LOW DENSITY LIPOPROTEIN DECREASED ( 1 patients )
CARDIAC FAILURE CONGESTIVE ( 1 patients )
APOLIPOPROTEIN E ( 1 patients )
COMPUTERISED TOMOGRAM CORONARY ARTERY ( 1 patients )
POLYMYALGIA RHEUMATICA ( 1 patients )
CARDIOMYOPATHY ( 1 patients )
DRUG LEVEL INCREASED ( 1 patients )
RESPIRATORY TRACT INFECTION ( 1 patients )
BLOOD PRESSURE SYSTOLIC INCREASED ( 1 patients )
POOR PERIPHERAL CIRCULATION ( 1 patients )
BENIGN PROSTATIC HYPERPLASIA ( 1 patients )
INTERMITTENT CLAUDICATION ( 1 patients )
CORONARY ARTERY INSUFFICIENCY ( 1 patients )
HIGH FAT DIET ( 1 patients )
POSTOPERATIVE CARE ( 1 patients )
ULCER ( 1 patients )
ADVERSE EVENT ( 1 patients )
BLOOD CALCIUM INCREASED ( 1 patients )
EMOTIONAL DISORDER ( 1 patients )
ORGANIC ERECTILE DYSFUNCTION ( 1 patients )
CORONARY ARTERY RESTENOSIS ( 1 patients )
MEMORY IMPAIRMENT ( 1 patients )
CORONARY ARTERY THROMBOSIS ( 1 patients )
PROTEIN TOTAL NORMAL ( 1 patients )
VASCULAR STENT INSERTION ( 1 patients )
ANGIOGRAM ABNORMAL ( 1 patients )
FLUID RETENTION ( 1 patients )
OVERDOSE ( 1 patients )
ARTHRALGIA ( 1 patients )
CALCIFICATION OF MUSCLE ( 1 patients )
DEMENTIA ( 1 patients )
ANTICOAGULANT THERAPY ( 1 patients )
CEREBROVASCULAR ACCIDENT PROPHYLAXIS ( 1 patients )
PAIN IN EXTREMITY ( 1 patients )
ARTHROPATHY ( 1 patients )
RENAL ARTERY OCCLUSION ( 1 patients )
VENOUS OCCLUSION ( 1 patients )
AORTIC ANEURYSM ( 1 patients )
HEART RATE IRREGULAR ( 1 patients )
LIPOPROTEIN (A) INCREASED ( 1 patients )
TOTAL CHOLESTEROL/HDL RATIO ( 1 patients )
VERTEBRAL ARTERY STENOSIS ( 1 patients )
DIZZINESS ( 1 patients )
HYPOTHYROIDISM ( 1 patients )
RENAL FAILURE ACUTE ( 1 patients )
AORTIC STENOSIS ( 1 patients )
COMBINED HYPERLIPIDAEMIA ( 1 patients )
LIVER INJURY ( 1 patients )
TRANSIENT ISCHAEMIC ATTACK ( 1 patients )
WEIGHT DECREASED ( 1 patients )
ABASIA ( 1 patients )
CARDIAC STRESS TEST ( 1 patients )
RENAL VESSEL DISORDER ( 1 patients )
HIGH DENSITY LIPOPROTEIN ABNORMAL ( 1 patients )
POLYMYOSITIS ( 1 patients )
DRUG THERAPY ( 1 patients )
INFLAMMATION ( 1 patients )
OBESITY ( 1 patients )
ADVERSE DRUG REACTION ( 1 patients )
BLOOD CALCIUM ( 1 patients )
ISCHAEMIC CARDIOMYOPATHY ( 1 patients )
OEDEMA PERIPHERAL ( 1 patients )
SCAN ABNORMAL ( 1 patients )
BLOOD TRIGLYCERIDES DECREASED ( 1 patients )
MEDICAL DEVICE CHANGE ( 1 patients )
PREDISPOSITION TO DISEASE ( 1 patients )
UNEVALUABLE EVENT ( 1 patients )
AMNESIA ( 1 patients )
BLOOD CHLORIDE ABNORMAL ( 1 patients )
ESSENTIAL HYPERTENSION ( 1 patients )
OROPHARYNGEAL PLAQUE ( 1 patients )
SKIN DISCOLOURATION ( 1 patients )
BONE DISORDER ( 1 patients )
VASCULAR OCCLUSION ( 1 patients )
CATHETER PLACEMENT ( 1 patients )
FEELING ABNORMAL ( 1 patients )
OSTEOPOROSIS ( 1 patients )
SPINAL DISORDER ( 1 patients )
ARTERITIS ( 1 patients )
CROHN'S DISEASE ( 1 patients )
MICROANGIOPATHY ( 1 patients )
PSORIATIC ARTHROPATHY ( 1 patients )
VASCULITIS ( 1 patients )
ANGIOPLASTY ( 1 patients )
LIPIDS DECREASED ( 1 patients )
OVERWEIGHT ( 1 patients )
Drugs with high FDA adverse event association with OCCIPITAL NEURALGIA:

FOSAMAX (133 patients)
ASPIRIN (30 patients)
XANAX (28 patients)
SYNTHROID (26 patients)
LASIX (25 patients)
HYDROCHLOROTHIAZIDE (23 patients)
FUROSEMIDE (22 patients)
ALPRAZOLAM (21 patients)
MULTI-VITAMINS (21 patients)
POTASSIUM CHLORIDE (21 patients)
ALTACE (20 patients)
AMOXICILLIN (20 patients)
CLARITIN (20 patients)
PREMARIN (20 patients)
AREDIA (19 patients)
ZOMETA (19 patients)
BIOTIN (19 patients)
CAL-MAG (19 patients)
ZESTRIL (19 patients)
CHROMIUM CHLORIDE (19 patients)
CRESTOR (19 patients)
CROCIN (19 patients)
SELENIUM (19 patients)
IMDUR (19 patients)
MAGNESIUM (17 patients)
FENTANYL (16 patients)
ALENDRONATE SODIUM (15 patients)
DECADRON (14 patients)
GABAPENTIN (14 patients)
VERSED (13 patients)
PHENERGAN (12 patients)
ACYCLOVIR (11 patients)
BORTEZOMIB (11 patients)
LYRICA (11 patients)
VANCOMYCIN (11 patients)
WARFARIN SODIUM (11 patients)
IMODIUM (11 patients)
ACTONEL (10 patients)
BACLOFEN (10 patients)
ZINC SULFATE (10 patients)
CODEINE (10 patients)
ZINC (10 patients)
LEXAPRO (10 patients)
LOSARTAN POTASSIUM (9 patients)
CODEINE SULFATE (9 patients)
FOSAMAX PLUS D (9 patients)
SEROQUEL (9 patients)
TOPAMAX (8 patients)
ASCORBIC ACID (8 patients)
CALCIUM (UNSPECIFIED) AND VITAMIN D (UNSPECIFIED) (8 patients)
WARFARIN (8 patients)
NEXIUM (8 patients)
CYMBALTA (8 patients)
ZINC (UNSPECIFIED) (8 patients)
ACETAMINOPHEN AND HYDROCODONE BITARTRATE (7 patients)
LORTAB (7 patients)
AMBIEN (7 patients)
TORSEMIDE (7 patients)
CALCIUM CARBONATE (7 patients)
CORTICOSTEROIDS (UNSPECIFIED) (7 patients)
CYCLOBENZAPRINE HYDROCHLORIDE (7 patients)
REVLIMID (7 patients)
IBUPROFEN (7 patients)
JANUVIA (7 patients)
ATENOLOL (6 patients)
NUVARING (6 patients)
ZOLOFT (6 patients)
ZYPREXA (6 patients)
NASONEX (6 patients)
FOLIC ACID (6 patients)
PREVACID (6 patients)
SOMA (6 patients)
KLONOPIN (6 patients)
LEVAQUIN (6 patients)
LISINOPRIL (6 patients)
ALBUTEROL (5 patients)
LOVAZA (5 patients)
AVONEX (5 patients)
CALCIUM (5 patients)
M.V.I. (5 patients)
CLONIDINE (5 patients)
COUMADIN (5 patients)
DEMEROL (5 patients)
DEPAKOTE (5 patients)
MONOPRIL (5 patients)
HYDROCODONE (5 patients)
HYDROCODONE BITARTRATE (5 patients)
LEVOXYL (5 patients)
ACETAMINOPHEN (4 patients)
PERCOCET (4 patients)
ALLEGRA (4 patients)
PRILOSEC (4 patients)
SPIRONOLACTONE (4 patients)
OXYCODONE HCL (4 patients)
CLONAZEPAM (4 patients)
TYLENOL-500 (4 patients)
DIAZEPAM (4 patients)
VITAMIN D (4 patients)
VITAMIN E (4 patients)
DULCOLAX (4 patients)
ENBREL (4 patients)
FLEXERIL (4 patients)
OMEPRAZOLE (4 patients)
OXYCONTIN (4 patients)
PANTOPRAZOLE (4 patients)
GLYCOLAX (4 patients)
SINGULAIR (4 patients)
LIPITOR (4 patients)
ULTRAM (4 patients)
ACLASTA (3 patients)
ALLOPURINOL (3 patients)
ALOXI (3 patients)
REBIF (3 patients)
AMLODIPINE (3 patients)
TOPROL-XL (3 patients)
NORVIR (3 patients)
POTASSIUM (3 patients)
BENADON (3 patients)
BENADRYL ^ACHE^ (3 patients)
TRUVADA (3 patients)
VITAMIN C (3 patients)
CARTIA XT (3 patients)
MUPIROCIN (3 patients)
CLINDAMYCIN (3 patients)
COLACE (3 patients)
COQ10 (3 patients)
COREG (3 patients)
CYANOCOBALAMIN (3 patients)
CYTOXAN (3 patients)
VICODIN (3 patients)
VINCRISTINE (3 patients)
VIOXX (3 patients)
ECHINACEA (3 patients)
EFFEXOR (3 patients)
ELIDEL (3 patients)
METHOTREXATE (3 patients)
METHYLPREDNISOLONE (3 patients)
FLUCONAZOLE (3 patients)
NEULASTA (3 patients)
NORCO (3 patients)
GLUCOSAMINE /CHONDROITIN /MSM (3 patients)
PREZISTA (3 patients)
PROTOPIC (3 patients)
PROZAC (3 patients)
SAW PALMETTO (3 patients)
SUPER B (3 patients)
TRILEPTAL (3 patients)
LEVOTHYROXINE SODIUM (3 patients)
LORAZEPAM (3 patients)
ABILIFY (2 patients)
ZYRTEC (2 patients)
VISATRIL (2 patients)
AMITRIPTYLINE HCL (2 patients)
AROMASIN (2 patients)
ZELNORM (2 patients)
METOCLOPRAMIDE (2 patients)
PREDNISONE (2 patients)
RESPINOL (2 patients)
SERZONE (2 patients)
VALSARTAN W/ HYDROCHLOROTHIAZIDE (2 patients)
CELEBREX (2 patients)
CENESTIN (2 patients)
METFORMIN HCL (2 patients)
CHERATUSSIN COUGH SYRUP (2 patients)
CIPROFLOXACIN (2 patients)
MS CONTIN (2 patients)
CITALOPRAM (2 patients)
COENZYM Q10 (2 patients)
SCOPOLAMINE (2 patients)
CYCLOBENZAPRINE (2 patients)
TRAZODONE HCL (2 patients)
TRIHEXYPHENIDYL HCL (2 patients)
DICLOFENAC SODIUM (2 patients)
DIGOXIN (2 patients)
DIOVAN (2 patients)
VITAMIN TAB (2 patients)
DUONEB (2 patients)
ZOCOR (2 patients)
ENALAPRIL MALEATE (2 patients)
MAGNESIUM SULFATE (2 patients)
EXTRA STRENGTH TYLENOL (2 patients)
METHOCARBAMOL (2 patients)
METOLAZONE (2 patients)
FEXOFENADINE (2 patients)
FIORICET (2 patients)
FISH OIL (2 patients)
MULTI-VITAMIN (2 patients)
FLONASE (2 patients)
FLUOCINONIDE (2 patients)
NITROGLYCERIN (2 patients)
NORVASC (2 patients)
OCUVITE NOS (2 patients)
GEODON (2 patients)
GLIPIZIDE (2 patients)
GLUCOPHAGE (2 patients)
GLUCOVANCE (2 patients)
PROTONIX (2 patients)
HUMIRA (2 patients)
HYDROXYZINE (2 patients)
SPIRIVA (2 patients)
TETRACYCLINE (2 patients)
TRELSTAR DEPOT (2 patients)
TRIAMCINOLONE (2 patients)
LAMICTAL (2 patients)
TRICOR (2 patients)
LANTUS (2 patients)
TYSABRI (2 patients)
LITHIUM (2 patients)
LOPID (2 patients)
LORATADINE (2 patients)
Most common side effects for patients taking CRESTOR:
MYALGIA (4284 patients)
PAIN IN EXTREMITY (2937 patients)
NAUSEA (2747 patients)
FATIGUE (2614 patients)
ASTHENIA (2444 patients)
PAIN (2444 patients)
DIZZINESS (2338 patients)
HEADACHE (2259 patients)
DYSPNOEA (2189 patients)
MALAISE (2081 patients)
ARTHRALGIA (2048 patients)
MUSCLE SPASMS (2007 patients)
MYOCARDIAL INFARCTION (1833 patients)
DIARRHOEA (1818 patients)
FLUSHING (1793 patients)
DRUG INEFFECTIVE (1747 patients)
FALL (1574 patients)
BACK PAIN (1570 patients)
OEDEMA PERIPHERAL (1542 patients)
MUSCULAR WEAKNESS (1492 patients)
CHEST PAIN (1490 patients)
VOMITING (1467 patients)
RHABDOMYOLYSIS (1451 patients)
PRURITUS (1401 patients)
INSOMNIA (1375 patients)
BLOOD CHOLESTEROL INCREASED (1366 patients)
DRUG DOSE OMISSION (1354 patients)
WEIGHT DECREASED (1315 patients)
HYPERTENSION (1205 patients)
BLOOD CREATINE PHOSPHOKINASE INCREASED (1148 patients)
GAIT DISTURBANCE (1137 patients)
CEREBROVASCULAR ACCIDENT (1111 patients)
BLOOD GLUCOSE INCREASED (1107 patients)
ANXIETY (1102 patients)
WEIGHT INCREASED (1090 patients)
ABDOMINAL PAIN (1044 patients)
DEPRESSION (1041 patients)
RENAL FAILURE ACUTE (1028 patients)
PARAESTHESIA (1014 patients)
FEELING ABNORMAL (1009 patients)
PYREXIA (986 patients)
CONSTIPATION (971 patients)
RENAL FAILURE (962 patients)
ABDOMINAL PAIN UPPER (940 patients)
RASH (938 patients)
HYPOAESTHESIA (902 patients)
PNEUMONIA (890 patients)
COUGH (889 patients)
DIABETES MELLITUS (873 patients)
GASTROOESOPHAGEAL REFLUX DISEASE (839 patients)
ALOPECIA (789 patients)
ATRIAL FIBRILLATION (766 patients)
BLOOD PRESSURE INCREASED (730 patients)
ANAEMIA (710 patients)
DRUG INTERACTION (709 patients)
DEHYDRATION (708 patients)
TREMOR (685 patients)
ERYTHEMA (677 patients)
BLOOD TRIGLYCERIDES INCREASED (676 patients)
DYSPEPSIA (675 patients)
CARDIAC DISORDER (661 patients)
DECREASED APPETITE (660 patients)
SOMNOLENCE (650 patients)
HYPERHIDROSIS (649 patients)
HYPOTENSION (642 patients)
VISION BLURRED (641 patients)
CARDIAC FAILURE CONGESTIVE (610 patients)
LOSS OF CONSCIOUSNESS (595 patients)
BLOOD CREATININE INCREASED (594 patients)
ABDOMINAL DISCOMFORT (591 patients)
MUSCULOSKELETAL PAIN (589 patients)
FEELING HOT (585 patients)
PALPITATIONS (576 patients)
CONFUSIONAL STATE (570 patients)
ALANINE AMINOTRANSFERASE INCREASED (550 patients)
DEATH (541 patients)
CHEST DISCOMFORT (533 patients)
ARTHRITIS (532 patients)
AMNESIA (526 patients)
BURNING SENSATION (516 patients)
URINARY TRACT INFECTION (513 patients)
ASPARTATE AMINOTRANSFERASE INCREASED (507 patients)
MEMORY IMPAIRMENT (507 patients)
HEPATIC ENZYME INCREASED (505 patients)
PANCREATITIS (502 patients)
ABDOMINAL DISTENSION (498 patients)
INJURY (497 patients)
HIGH DENSITY LIPOPROTEIN DECREASED (493 patients)
NECK PAIN (489 patients)
CORONARY ARTERY DISEASE (481 patients)
DRY MOUTH (475 patients)
URTICARIA (463 patients)
JOINT SWELLING (462 patients)
CONDITION AGGRAVATED (447 patients)
NASOPHARYNGITIS (446 patients)
SYNCOPE (443 patients)
OFF LABEL USE (439 patients)
CHRONIC OBSTRUCTIVE PULMONARY DISEASE (436 patients)
OSTEOARTHRITIS (429 patients)
NEUROPATHY PERIPHERAL (428 patients)
BRONCHITIS (426 patients)
LOW DENSITY LIPOPROTEIN INCREASED (426 patients)
BALANCE DISORDER (415 patients)
CONTUSION (413 patients)
LIVER FUNCTION TEST ABNORMAL (408 patients)
RENAL IMPAIRMENT (405 patients)
CHILLS (405 patients)
ILL-DEFINED DISORDER (403 patients)
HEART RATE INCREASED (403 patients)
ABASIA (402 patients)
CONVULSION (402 patients)
POLLAKIURIA (401 patients)
HYPERSENSITIVITY (399 patients)
MUSCULOSKELETAL STIFFNESS (395 patients)
FLATULENCE (390 patients)
WRONG TECHNIQUE IN DRUG USAGE PROCESS (389 patients)
DYSGEUSIA (388 patients)
DYSPHAGIA (376 patients)
HOT FLUSH (374 patients)
ASTHMA (363 patients)
CORONARY ARTERY OCCLUSION (353 patients)
LIVER DISORDER (352 patients)
INTENTIONAL DRUG MISUSE (350 patients)
CHROMATURIA (343 patients)
TRANSIENT ISCHAEMIC ATTACK (342 patients)
HYPERLIPIDAEMIA (335 patients)
VISUAL IMPAIRMENT (334 patients)
INFLUENZA LIKE ILLNESS (334 patients)
INTERSTITIAL LUNG DISEASE (332 patients)
ANGINA PECTORIS (331 patients)
SWELLING (326 patients)
TYPE 2 DIABETES MELLITUS (322 patients)
OEDEMA (320 patients)
NEOPLASM MALIGNANT (315 patients)
INCORRECT DOSE ADMINISTERED (307 patients)
HAEMORRHAGE (306 patients)
PLEURAL EFFUSION (306 patients)
PULMONARY EMBOLISM (304 patients)
SINUSITIS (304 patients)
BONE PAIN (303 patients)
DYSURIA (301 patients)
SEPSIS (298 patients)
EPISTAXIS (298 patients)
DEEP VEIN THROMBOSIS (295 patients)
THROMBOCYTOPENIA (294 patients)
CATARACT (293 patients)
CHOLELITHIASIS (291 patients)
DRUG HYPERSENSITIVITY (291 patients)
NERVOUSNESS (285 patients)
HAEMOGLOBIN DECREASED (284 patients)
CARDIAC FAILURE (283 patients)
ADVERSE EVENT (283 patients)
ARRHYTHMIA (282 patients)
GENERAL PHYSICAL HEALTH DETERIORATION (281 patients)
BLOOD PRESSURE DECREASED (279 patients)
STRESS (278 patients)
INTERNATIONAL NORMALISED RATIO INCREASED (278 patients)
INFECTION (274 patients)
OROPHARYNGEAL PAIN (274 patients)
HYPERKALAEMIA (272 patients)
CELLULITIS (272 patients)
PLATELET COUNT DECREASED (272 patients)
HEPATIC FUNCTION ABNORMAL (268 patients)
ROAD TRAFFIC ACCIDENT (268 patients)
EMOTIONAL DISTRESS (264 patients)
INFLUENZA (263 patients)
TACHYCARDIA (263 patients)
CARDIAC ARREST (263 patients)
SWELLING FACE (259 patients)
BLOOD GLUCOSE DECREASED (257 patients)
RESPIRATORY FAILURE (256 patients)
GOUT (254 patients)
BLOOD UREA INCREASED (253 patients)
RENAL FAILURE CHRONIC (252 patients)
HYPERCHOLESTEROLAEMIA (249 patients)
LETHARGY (249 patients)
MIGRAINE (249 patients)
OSTEOPOROSIS (247 patients)
BREAST CANCER (247 patients)
MOBILITY DECREASED (247 patients)
STENT PLACEMENT (247 patients)
VERTIGO (246 patients)
HAEMATURIA (245 patients)
HYPOGLYCAEMIA (244 patients)
RENAL DISORDER (243 patients)
DYSPHONIA (243 patients)
NEPHROLITHIASIS (241 patients)
PANCREATITIS ACUTE (241 patients)
MYOPATHY (239 patients)
TINNITUS (237 patients)
THROMBOSIS (234 patients)
BONE DISORDER (234 patients)
HYPOKALAEMIA (229 patients)
OSTEONECROSIS OF JAW (229 patients)
BRADYCARDIA (229 patients)
HEPATITIS (229 patients)
INTERVERTEBRAL DISC PROTRUSION (228 patients)
GASTROINTESTINAL HAEMORRHAGE (227 patients)
ARTHROPATHY (227 patients)
ERECTILE DYSFUNCTION (226 patients)
SPEECH DISORDER (224 patients)
SLEEP DISORDER (223 patients)
SUICIDAL IDEATION (222 patients)
ARTERIAL OCCLUSIVE DISEASE (219 patients)
HYPERGLYCAEMIA (218 patients)
HIATUS HERNIA (216 patients)
INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION (214 patients)
SKIN BURNING SENSATION (213 patients)
HEART RATE IRREGULAR (212 patients)
MUSCLE ATROPHY (212 patients)

In addition to reviewing our up-to-date FDA research, users may interact with the FactMed community - currently one million members and growing! FactMed online research and discussions are read by patients, scientists, physicians, and other interested health care parties. Post follow up Questions to learn from our diverse readership. Likewise, patients who have experienced unwanted effects are encouraged to share their Concerns to help educate and inform our members.


Recent FactMed Activity for CRESTOR


Issue Description / Topic Timestamp

My Patient Resources

Get your questions answered! Over one million patients, researchers, and health care providers have visited FactMed. If you have a question about OCCIPITAL NEURALGIA and CRESTOR, post it here. You may receive a response from a fellow patient - or a leading expert in the field.
Your Question:

Share your experience: Over one million patients, researchers, and health care providers have visited FactMed. If you have a noteworthy experience as a patient taking CRESTOR, post it here. Your story could help a fellow patient - or provide insight to a leading expert in the field.
Your Experience or Concern:

Telemedicine Expert Consults FactMed newest feature allows patients to consult - via realtime videoconferencing - experts in CRESTOR. This premium feature connects patients to experts, regardless of geography. FactMed experts charge reasonable rates that may be reimbursable by your insurance as a second-opinion.
We are currently accepting registration for CRESTOR experts. If you are a healthcare provider experienced in prescribing CRESTOR, please register here.
© 2014 FactMed, Inc
Privacy Policy
Terms of Use